Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

141.56
+8.956.75%
Volume:509.09K
Turnover:71.10M
Market Cap:6.32B
PE:-14.52
High:142.49
Open:133.35
Low:133.31
Close:132.61
52wk High:166.48
52wk Low:41.50
Shares:44.67M
Float Shares:40.73M
Volume Ratio:0.51
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.7487
EPS(LYR):-11.1105
ROE:-16.12%
ROA:-12.03%
PB:2.49
PE(LYR):-12.74

Loading ...

Grail Shares Jump 34.6% as US FDA Flags no Major Concerns for Co's Cancer Test

THOMSON REUTERS
·
Sep 21

Grail Stock Soars 33% Ahead of Multi-Cancer Blood Test Review from FDA

Dow Jones
·
Sep 21

Grail rallies after FDA releases briefing documents for Galleri test review

TIPRANKS
·
Sep 21

Grail rises 23.2%

TIPRANKS
·
Sep 21

GRAIL Risk-Reward Attractive Ahead of FDA Advisory Committee, UBS Says

MT Newswires Live
·
Sep 19

Grail's Galleri Test Has Large Market Potential Amid Adoption Curve Concerns, RBC Capital Markets Says

MT Newswires Live
·
Sep 17

RBC Initiates GRAIL at Sector Perform With $84 Price Target

MT Newswires Live
·
Sep 17

Grail initiated with a Sector Perform at RBC Capital

TIPRANKS
·
Sep 17

UBS Initiates a Buy Rating on GRAIL Inc (GRAL)

TIPRANKS
·
Sep 14

Grail Initiated at Buy by UBS

Dow Jones
·
Sep 09

UBS Initiates Coverage on GRAIL With Buy Rating, $105 Price Target

MT Newswires Live
·
Sep 09

Grail Grants 55,867 Inducement RSUs to 59 New Hires Under NASDAQ Rule 5635(c)(4)

Reuters
·
Sep 04

Grail CEO Joshua J. Ofman Sells 5,000 Common Shares for $425,098‬

Reuters
·
Sep 01

Grail to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 01

GRAIL (GRAL) Is Down 6.5% After FDA Sets Galleri PMA Panel Review – Has The Bull Case Changed?

Simply Wall St.
·
Aug 18

GRAIL (GRAL) Could Be 5% Overvalued As FDA Review Date Sharpens Focus

Simply Wall St.
·
Aug 09

GRAIL Says FDA Advisory Committee to Review GRAIL Galleri PMA Application on September 23

Reuters
·
Aug 07

US FDA to Hold Advisory Meeting to Review Grail's Multi-Cancer Test

Reuters
·
Aug 07

Grail announces FDA advisory committee meeting to review Galleri test PMA

TIPRANKS
·
Aug 07

Grail Says FDA Advisory Panel Meets Sept. 23 on Galleri Test PMA Review

Reuters
·
Aug 07